CUE BIOPHARMA INC (CUE)       3.2  -0.14 (-4.19%)

3.2  -0.14 (-4.19%)

US22978P1066 - Common Stock - After market: 3.36 +0.16 (+5%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 -0.37 -0.43 0.0613.46% Q1 2022 -0.44 -0.43 -0.01-1.90% Q4 2021 -0.25 -0.39 0.1435.71% Q3 2021 -0.41 -0.39 -0.02-4.09% Q2 2021 -0.33 -0.42 0.0921.46% Q1 2021 -0.41 -0.38 -0.03-7.39% Q4 2020 -0.36 -0.35 -0.01-1.84% Q3 2020 -0.34 -0.39 0.0512.33%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.69 -1.40 -21.02%Q3 2022 -0.40 -0.41 2.28%Q4 2022 -0.32 -0.25 -29.28%FY 2023 -1.81 -1.69 -7.00%Q1 2023 -0.37 -0.44 15.07%Q2 2023 -0.42 -0.37 -14.65%Q3 2023 -0.37 -0.40 6.72%Q4 2023 -0.37 -0.32 -14.06%FY 2024 -1.69 -1.81 6.96%FY 2025 -1.67 -1.69 1.01%FY 2026 -1.67 -1.67 0.02%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 26K 1.143M -1.117M-97.72% Q1 2022 1M 3.085M -2.085M-67.58% Q4 2021 8.254M 2.996M 5.259M175.54% Q3 2021 2.395M 1.884M 511.098K27.13% Q2 2021 2.739M 1.068M 1.671M156.56% Q1 2021 1.55M 591.456K 958.544K162.07% Q4 2020 480K 1.346M -865.724K-64.33% Q3 2020 700K 1.712M -1.012M-59.12%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 9.262M 14.941M -38.01%Q3 2022 1.144M 2.395M -52.25%Q4 2022 5.721M 8.254M -30.69%FY 2023 9.98M 9.262M 7.76%Q1 2023 2.045M 1M 104.53%Q2 2023 2.072M 26K 7,869.29%Q3 2023 2.1M 1.144M 83.60%Q4 2023 2.129M 5.721M -62.79%FY 2024 12.794M 9.98M 28.19%FY 2025 14.944M 12.794M 16.81%FY 2026 17.63M 14.944M 17.97%